Rip1 Mediates the Trif-dependent Toll-like Receptor 3- and 4-induced NF-κB Activation but Does Not Contribute to Interferon Regulatory Factor 3 Activation*
暂无分享,去创建一个
Katherine A. Fitzgerald | M. Kelliher | K. Fitzgerald | Thomas H. Lee | Nicole Cusson-Hermance | Smriti Khurana | Michelle A. Kelliher | Nicole Cusson-Hermance | S. Khurana
[1] Zhijian J. Chen,et al. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. , 2004, Molecular cell.
[2] T. Maniatis,et al. A Drosophila IkappaB kinase complex required for Relish cleavage and antibacterial immunity. , 2000, Genes & development.
[3] Sophie Janssens,et al. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. , 2003, Molecular cell.
[4] S. Der,et al. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Tschopp,et al. Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation , 2003 .
[6] F. Martinon,et al. RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation , 2004, Nature Immunology.
[7] B. Williams,et al. Poly(dI·dC)-induced Toll-like Receptor 3 (TLR3)-mediated Activation of NFκB and MAP Kinase Is through an Interleukin-1 Receptor-associated Kinase (IRAK)-independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR* , 2003, The Journal of Biological Chemistry.
[8] S. Akira,et al. Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.
[9] Aseem Kumar,et al. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Inoue,et al. Cutting Edge: TNFR-Associated Factor (TRAF) 6 Is Essential for MyD88-Dependent Pathway but Not Toll/IL-1 Receptor Domain-Containing Adaptor-Inducing IFN-β (TRIF)-Dependent Pathway in TLR Signaling1 , 2004, The Journal of Immunology.
[11] Makoto Nakanishi,et al. A20 Is a Negative Regulator of IFN Regulatory Factor 3 Signaling1 , 2005, The Journal of Immunology.
[12] Shizuo Akira,et al. Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-β (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-κB and IFN-Regulatory Factor-3, in the Toll-Like Receptor Signaling 1 , 2003, The Journal of Immunology.
[13] Hong-Bing Shu,et al. A20 is a potent inhibitor of TLR3‐ and Sendai virus‐induced activation of NF‐κB and ISRE and IFN‐β promoter , 2004 .
[14] D. Goeddel,et al. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. , 1996, Immunity.
[15] B. Su,et al. The Death Domain Kinase RIP1 Is Essential for Tumor Necrosis Factor Alpha Signaling to p38 Mitogen-Activated Protein Kinase , 2003, Molecular and Cellular Biology.
[16] G Cantarella,et al. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.
[17] S. Akira,et al. Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.
[18] Somasekar Seshagiri,et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.
[19] Shizuo Akira,et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.
[20] G. Barber,et al. A FADD-dependent innate immune mechanism in mammalian cells , 2004, Nature.
[21] M. Kelliher,et al. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. , 2000, Immunity.
[22] Stefan Grimm,et al. The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal , 1998 .
[23] B. Seed,et al. RIP mediates tumor necrosis factor receptor 1 activation of NF‐kappaB but not Fas/APO‐1‐initiated apoptosis. , 1996, The EMBO journal.
[24] S. Akira,et al. Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.
[25] S. Lemon,et al. Distinct Poly(I-C) and Virus-activated Signaling Pathways Leading to Interferon-β Production in Hepatocytes* , 2005, Journal of Biological Chemistry.
[26] S. Vogel,et al. Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.
[27] T. Maniatis,et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway , 2003, Nature Immunology.
[28] Matthew T Wheeler,et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.
[29] M. Kelliher,et al. The Kinase Activity of Rip1 Is Not Required for Tumor Necrosis Factor-α-induced IκB Kinase or p38 MAP Kinase Activation or for the Ubiquitination of Rip1 by Traf2* , 2004, Journal of Biological Chemistry.
[30] T. Maniatis,et al. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. , 1998, Molecular cell.